This Meno Life

You'd been working up to it for weeks. Then somewhere around minute four you said it out loud: I think I want to talk about hormones. The answer came back before you finished the sentence. We don't really do that here. Let's not go there. You got out to the parking lot before you thought of the question you actually wanted to ask.Dr. Siân West, board-certified OB-GYN and menopause specialist, reads out the actual labeled contraindications, names what is not on that list, and gives you the questions that separate a real medical no from a reflex. Most of the episode sits on three things.First, 2002. The Women's Health Initiative stopped one arm of a large trial early. Women taking conjugated equine estrogen with a synthetic progestin called MPA were showing more breast cancer than women on placebo. The story ran everywhere, prescriptions collapsed inside a year, and a generation of clinicians trained in the weather it created. What didn't make the news was the size: eight additional cases of invasive breast cancer per ten thousand women per year. Real, and small enough that hormones cause cancer isn't a fair summary of what that study found. The signal was tied to that specific progestin rather than to hormone therapy as a category. In the other arm of the same study, women who'd had a hysterectomy took estrogen alone, and their breast cancer rate came in lower than placebo.Second, the list, read out in full. Undiagnosed abnormal genital bleeding. A personal history of breast cancer. A known or suspected estrogen-dependent cancer. An active or previous blood clot. A stroke or heart attack in the past year. Liver disease. Pregnancy. An allergy to the drug. And porphyria cutanea tarda. That is all of it. Your mother's breast cancer is not on it. Your age is not on it. Fibroids are not on it. A clotting disorder on its own is not on it. Then the second way a no can be real: the guidelines disagree and you get handed one reading as settled. The CDC and WHO restriction on estrogen in migraine with aura is about contraception, and the menopause society's own clinician's guide states that a similar contraindication has not been identified at menopausal doses.Third, testosterone, where the door often opens only partway. Plenty of clinicians who write for estrogen stop cold at testosterone, and there is a real reason: no testosterone product is FDA-approved for women in the United States, so prescribing it means going off-label with monitoring. What the evidence supports, why a normal level is a monitoring tool rather than an entry requirement, and why compounded pellets carry less oversight than the off-label gel.Touched on more briefly: route and clot risk, progesterone if you still have your uterus, vaginal estrogen, age, and non-hormonal options.And three patterns from practice. Women offered the birth control pill as the only option. Women refused MHT over a relative's breast cancer. And one perimenopausal woman doing well on MHT, not needing contraception, whose OB-GYN switched her to the pill because the pills would just be better. Her hot flashes came back.You leave with four sentences for the next appointment, and a way to find a menopause-trained clinician if you need a different room.In this episode:What the WHI actually found in 2002, and what the estrogen-alone arm foundThe labeled contraindication list, read out loud, and what is not on itWhere the migraine with aura restriction actually comes fromWhy clinicians who write for estrogen often will not write for testosteroneWhy a normal testosterone level is a monitoring result, not a gateWhy compounded testosterone pellets carry less oversight, not moreA clinician saying no quickly and the evidence saying no sound identical from where you're sitting. You're allowed to find out which one you got.

Twelve people tell you the presentation was excellent. One person mentions the timeline could have been tighter. It is eleven at night and you are still thinking about the timeline.Dr. Siân West, board-certified OB-GYN and menopause specialist, takes apart imposter syndrome in midlife women: why it resurfaces in your forties and fifties, why perimenopause brain fog makes it worse, and what actually helps.The pattern has a name and about fifty years of research behind it. Impostor phenomenon was first described in 1978 by psychologists Pauline Clance and Suzanne Imes, and their subjects were not underachievers. They were high-achieving women with real credentials who were privately convinced they had fooled everyone. A 2024 meta-analytic review of more than a hundred studies and over forty thousand participants found women scoring higher than men on measures of imposter feelings. The gap is modest and varies by field, but it is real and it has not shrunk over time. One survey of women executives put it at seventy five percent. In a survey of UK orthopedic surgeons, ninety two percent reported moderate to intense imposter feelings, women scored higher than men, and almost half said it had discouraged them from applying for leadership roles.The episode separates two things that get confused constantly: being genuinely new at something, and being a fraud. Being a beginner at a format is not the same as being a beginner at the work. Siân talks openly about her own version of this, from a year spent opening a telehealth practice, posting online and launching this show in public.It also makes the connection to what your body may be doing right now. Perimenopausal cognitive change is measurable. In the SWAN cohort, women were given the same cognitive test repeatedly over four years. Premenopausal and postmenopausal women improved with practice, which is what normally happens. Women in late perimenopause did not. Their scores did not decline, they simply stopped improving, and the effect resolved after the transition. If you are already primed to doubt your competence, a blanked-out name in a meeting does not land as a hormone thing. It lands as confirmation. That is a hormonal transition affecting focus and word retrieval. It is not a verdict on whether you know your job.If you have been losing your train of thought mid-sentence, blanking on a word you have known for thirty years, or going back to work after time away and feeling like a visitor in your own career, this one is for you.In this episode:What the 1978 impostor phenomenon research found, and who Clance and Imes actually studiedWhat the 2024 meta-analytic review shows about the gender gap in imposter feelingsWhy imposter syndrome spikes in midlife: returning to work, watching younger colleagues move up, wondering whether your moment passedWhy "fake it till you make it" makes it worseWhat the SWAN study found about perimenopause and cognitive performance, and why the finding is more reassuring than the headlinesHow brain fog feeds self-doubt directlyThe difference between being new at the format and being new to the workWhy 92 percent of surgeons in one survey reported imposter feelings, and what it cost themThree things to do: the friend test, a script for the moment it hits, and an evidence file on your phoneFeeling like you do not fully know what you are doing is usually a sign you understand how much there is to know.

A man walks into an office and says he is having trouble in the bedroom. Fifteen minutes later he walks out with a prescription. A woman walks in and says something is off, or this pain is not normal, and a lot of the time she walks out with a suggestion to see a therapist or manage her stress.Same building. Same kind of complaint. Very different response. Dr. Siân West, board-certified OB-GYN and menopause specialist, walks through what the research actually shows.Sildenafil, the drug we know as Viagra, was approved by the FDA in 1998 after roughly a six-month priority review. The first approved drug for low sexual desire in women, flibanserin, did not arrive until 2015. Seventeen years later, and only after being rejected twice.This episode puts both drugs side by side, which almost nobody does. Viagra worked well in its trials, taking men from about 1.5 successful attempts a month to about 5.9. Flibanserin worked modestly, about half an additional satisfying event a month. But the reason those numbers differ is the point. Blood flow had been studied for decades. Female sexual desire had almost no foundational science behind it, so the drug that finally arrived had almost nothing to build on.The safety comparison runs the other way. Flibanserin carries a boxed warning, for low blood pressure and fainting. Viagra has never carried one, despite a nitrate contraindication that can be fatal, sudden permanent vision loss, sudden hearing loss, and priapism that can cause permanent damage. 128 deaths were reported in association with Viagra in its first eight months on the US market. The FDA strengthened the label wording. The drug stayed on the market and kept its six-month approval.The pattern does not stop at which drugs get made. A 2024 study of nearly twenty two thousand emergency department records in the United States and Israel found women were less likely to be given pain medication than men at every pain score and in every age group, and their pain score was ten percent less likely to be recorded by the triage nurse at all. The same bias appeared with male and female clinicians alike.Research on nearly four hundred thousand heart attack admissions in the nineteen nineties found women under fifty died in hospital at more than twice the rate of men the same age. Separate work on patients fifty and under found young women were less likely to be discharged on the right medications, and less likely to have had their arteries looked at.The root of it: until 1993, FDA policy kept women of childbearing age out of early-stage drug trials in the United States. Decades of foundational work on pain, drug response and basic physiology was built on a study population that skewed heavily male, and then applied to everyone.In this episode:- The approval timeline, and the thirty-year head start sitting behind it- The side by side almost nobody runs: what each drug does, and what each one is allowed to do to you- What the 2024 pain study found at every single pain score, and whose pain gets written down at all- Why "women just report more pain" does not explain the gap- The exact sentence to use when a physical symptom gets blamed on stress: I would like this looked at as a physical symptom first- How to ask what specifically is being ruled out, and how- Why a second opinion is not dramaticThis is not an argument that individual clinicians are careless. Most people in medicine are trying, inside a system trained on incomplete information. The pattern is still real, and still measurable.

You have not slept properly in months. Your cycle has gone from clockwork to unpredictable. You lost a word mid sentence on a work call and just sat there. You have been treating each of those as its own separate mystery.They are one thing, and it has a name.Dr. Siân West, board-certified OB-GYN and menopause specialist, explains what perimenopause actually is. Menopause itself is a single point in time, defined medically as twelve consecutive months without a period. Everything leading up to it, all the years of change, is perimenopause. For most women it starts in the mid-forties, though it can begin in the late thirties, and it typically lasts four to eight years. The average age at the final period is around fifty one.Then the part almost nobody explains well. Perimenopause is not a steady decline. It is not your hormones turning down like a dimmer switch. It is estrogen and progesterone swinging unpredictably, month to month and sometimes week to week. That turbulence is the mechanism behind nearly everything you are feeling. It is also why a single hormone blood test drawn on one particular day can look completely normal and tell a different story a week later. Your pattern of symptoms over time is usually more reliable than one snapshot.In this episode:Perimenopause versus menopause, defined properly, with the timeline and the average age at the final periodWhy "swinging, not declining" changes how the whole symptom list readsWhy estrogen receptors throughout the body mean this was never only about your cycleHot flashes, night sweats, broken sleep, mood swings, brain fog and new joint aches, reframed through the fluctuation lensWhy perimenopausal brain fog tends to improve for most women after the transitionWhy hormone testing is often not necessary to make this diagnosis after a certain ageThe two things worth tracking for the next two to three months, and a script for your next appointmentNot everyone gets every symptom, or in the same order or intensity. Some women barely notice it. Some get hit with almost everything at once. Both are normal versions of the same transition.

Perimenopause arrives without an announcement. Night sweats, words that ghosted you mid-sentence, a rage that arrives before you do, jeans that betrayed you overnight, and a sex life that used to be uncomplicated and now requires a strategy meeting.You pay your copay. Your labs come back normal. You leave empty handed.This Meno Life is a weekly show for women in perimenopause and menopause. I'm Dr. Sian West, board-certified OB-GYN and menopause specialist, and I spend my days on the questions a short appointment never reaches.The hot flashes and the sleep that fell apart. The weight that arrived without a single change in your habits. The rage that shows up out of proportion to whatever caused it, and the moods that swing hard enough to scare you. Painful sex and vaginal dryness, which not only did nobody warn you about, nobody likes to talk about, and far too few clinicians are trained to treat it.And the bigger one underneath all of it: the woman in the mirror who you do not entirely recognise anymore.We'll talk about MHT, what the evidence actually supports and where it's honestly thin.It's also a show about the rest of it. The mental load. The career still in progress. Being awake since 3am and still being the one everyone needs.What it isn't: a supplement pitch, a fear campaign, or a soft place to land. You will not be told to embrace this chapter or navigate your journey. You're an adult with a body, a schedule, and a limited tolerance for nonsense.We say it out loud here.Dismissal is not a diagnosis. Follow along so it's never yours.